CERS Cerus Corporation

NASDAQ
$1.94

Cerus Corporation (CERS) is expected to report earnings on February 1, 2027, after the market close. The consensus earnings estimate is $0.00 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -8.5% since its last earnings release on November 2, 2026.

Cerus Beat Consensus Estimates, Reaffirms
Monday, November 2, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 1
Monday · 4:05 PM ET
Earnings Whisper
-
vs $0.00
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $2.05

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Cerus Corporation

Cerus Corp is a biomedical products company. It is engaged in developing and commercializing the INTERCEPT Blood System to enhance blood safety.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.